159 filings
Page 2 of 8
8-K
rvjbigxr 96
7 Aug 23
Exagen Inc. Reports Strong Second Quarter 2023 Results
8:00am
8-K
niodgqt2if2x2
24 Jul 23
Exagen Inc. Appoints Paul Kim to Board of Directors
4:05pm
8-K
o69i42i73fct771bej
14 Jun 23
Submission of Matters to a Vote of Security Holders
4:50pm
DEFA14A
9hlzv kjb
24 May 23
Additional proxy soliciting materials
4:05pm
S-8
464m0dkklzg
18 May 23
Registration of securities for employees
4:06pm
8-K
b2py b20oo
15 May 23
Exagen Inc. Reports First Quarter 2023 Results
4:05pm
8-K
uh8ud98mj rwoekr
4 May 23
Entry into a Material Definitive Agreement
9:00am
ARS
me21p6805nb fj
28 Apr 23
Annual report to shareholders
4:06pm
DEFA14A
il4y3vqz41w28t
28 Apr 23
Additional proxy soliciting materials
4:06pm
8-K
ju49r
23 Mar 23
Departure of Directors or Certain Officers
9:00am
8-K
9fn77f 11o6w0x
20 Mar 23
Exagen Inc. Reports Fourth Quarter and Full Year 2022 Results
4:05pm
8-K
k22e39908duw
23 Jan 23
Exagen Inc. Elects Tina S. Nova, Ph.D. as Executive Chair of the Board of Directors
9:00am
8-K
ape0mt6cu
9 Jan 23
Results of Operations and Financial Condition
9:00am
8-K
d57b2zk3j
5 Dec 22
Cost Associated with Exit or Disposal Activities
4:22pm
NT 10-Q
ik1 9x2mgp
14 Nov 22
Notice of late quarterly filing
4:12pm